Menu button

Published May 2012

Download PDF Document

Reviewed October 2015; no update needed.

Clinical Issues Committee American Society for Metabolic and Bariatric Surgery


Obstructive sleep apnea (OSA) is prevalent in the bariatric surgical population.  The condition has a negative effect on long-term health.  OSA may require treatment with ventilatory aids such as continuous positive airway pressure (CPAP) machines.  Surgical treatment of OSA is also possible.  Bariatric operations, and the weight loss they produce, result in improvements in various measurable parameters of OSA.  This guideline is a summary of recommendations for the peri-operative management of OSA based on currently available evidence and expert opinion.  The statement is not intended as, and should not be construed as, stating or establishing a local, regional, or national standard of care.  The statement may be revised in the future as additional evidence becomes available.


Obstructive sleep apnea (OSA) is the periodic reduction (hypopnea) or cessation (apnea) of breathing due to narrowing or occlusion of the upper airway during sleep.    The altered breathing pattern results in hypoxia and sleep disturbance preventing restful sleep.  Although some patients may be asymptomatic, loud snoring, restlessness and periods of apnea while sleeping, daytime somnolence, feeling unrefreshed after sleep, and the ability to easily fall asleep, are classic symptoms for this condition.

OSA is thought to affect between 17 and 24 percent of North American adults 1 and severely affect 2-6%. The incidence of OSA in the morbidly obese population is increased, and has been reported between 38% and 88%. 2-5  OSA has been linked to premature death 6 , traffic accidents 7 , hypertension 8 , ischemic heart disease, stroke 9 , type II diabetes 10 , increased neck circumference 11,12 , and visceral obesity 13 .  It has been associated with a significantly increased incidence of sudden death from cardiac causes 14 as well as an increased incidence of nocturnal cardiac arrhythmias 15 and chronic or acute adverse cardiovascular events. 16

The actual mechanism of OSA is believed to be secondary to increased tissue thickness of the structures of the tongue and soft tissues in the pharyngeal cavity which decrease the relative passageway for air to the trachea. 17  The protective muscles of the oropharynx have increased tone during the day to protect a patent airway.  They relax during sleep, resulting in relative obstruction of the airway.  When excessive soft tissue in the surrounding structures is present, the obstruction can lead to sleep-disordered breathing if mild, or obstructive apnea if more severe.  Decrease in the volume of these soft tissue structures after weight loss is hypothesized to produce improvement of OSA. Increased levels of inflammatory cytokines and decreased expression of inflammatory regulators have also been observed among obese patients with OSA, although this mechanism has yet to be fully elucidated. 12,13

Diagnosis of OSA based on physical examination and review of past medical history is difficult.  Several screening tools for sleepiness have been developed, such as the Epworth Sleepiness Score, the Maintenance of Wakefulness Test, the Berlin Questionnaire and the STOP-BANG Questionnaire, with variable sensitivities and specificities. 18  The standard method of diagnosing OSA is via polysomnography (PSG), which requires an overnight stay in a sleep laboratory.  During each hour of sleep, the number of apneas, defined as complete cessation of airflow, and hypopneas, defined as a 50-90% decrease in airflow and at least a 4% drop in oxygen saturation for >10 seconds, are recorded.  An “apnea hypopnea index” (AHI), or “respiratory disturbance index” (RDI) is used to quantitate these hypopneas and classify the degree of sleep disturbance.  In general, an AHI of less than 5 is normal, 5-15 mild sleep apnea, > 15 moderate sleep apnea, and ≥ 30 severe sleep apnea. 19  The role of the sleep laboratory is to substantiate the diagnosis and degree of sleep apnea, determine its cause if possible, and make recommendations for treatment (requirement for and level of continuous positive airway pressure (CPAP) or bi-level positive airway pressure (Bi-level PAP).

An associated pulmonary condition, in addition to OSA, seen in patients with extreme morbid obesity while awake is the Obesity Hypoventilation Syndrome.  This syndrome, similar to the Pickwickian syndrome of medical texts, involves significant abnormalities of pulmonary physiology from longstanding severe obesity, pulmonary hypertension, right-sided cardiac failure, and abnormalities of arterial gas exchange at rest.  These patients have high resting arterial pCO2 levels, depressed arterial pO2 levels, elevated hematocrits, and dyspnea at minimal exertion or at rest.  They are at high risk for pulmonary complications from any surgical intervention, and have an increased risk for venous thromboembolic complications as well. 20,21  OSA has been associated with an increased rate of 30-day mortality, venous thromboembolism, need for reintervention and a longer length of hospital stay. 22  Preoperative blood gas levels, ICU or step-down continuous monitoring postoperatively, and consideration of pulmonary artery catheter monitoring in the postoperative setting are all appropriate for obesity hypoventilation syndrome.

Incidence of Obstructive Sleep Apnea and Preoperative Screening

OSA is a common condition in the general population with increasing prevalence in the obese and morbidly obese populations. The general prevalence of obstructive sleep apnea with daytime somnolence is 3-7% of adult men and 2-5% of adult women. 23-25  The prevalence of OSA is affected by age, gender, ethnicity, associated conditions (pregnancy, hypothyroidism), smoking, alcohol and most strikingly, excess weight and obesity. The overall incidence of OSA in the bariatric population is believed to be 12 to 30 fold higher. 26,27  Preoperative sleep studies prior to bariatric surgery demonstrate an overall prevalence rate ranging from 48 to 91%. 3,4,28,29,30  These studies also show that OSA continues to be under-diagnosed in patients with morbid obesity and that a lower threshold for diagnosis, and intervention may be warranted. 3

While some reports in the literature recommend routine screening for OSA prior to bariatric surgery3, other reports suggest clinical screening only does not result in any increase in postoperative pulmonary complications after laparoscopic RYGB. 31  Most current surgical practices refer patients with clinical symptoms of OSA for polysomnography, but do not make this a routine preoperative test prior to bariatric surgery.

Obstructive Sleep Apnea:  Medical and Other Non-Bariatric Surgical Therapies

Medical Treatment

CPAP is the mainstay treatment for moderate to severe OSA and has been shown to improve objective and subjective measures of OSA. 32,33  Although the optimal form of CPAP delivery has not yet been determined, a variety of devices are available that may be useful alternatives when a patient is unable to tolerate conventional nasal masks.  A face mask should be considered if nasal obstruction or dryness limits the use of a nasal mask. 32,33   Poor adherence to CPAP is widely recognized as a significant limiting factor for OSA treatment. 34,35

CPAP has been shown to be a highly effective treatment for OSA if appropriately used.  There is evidence that CPAP may lead to an improvement in hypertension, especially for patients with moderate to severe OSA. 32,33,36

CPAP has been shown to improve sleepiness in 2-3 weeks. 37,38  There is, however, no data in the literature regarding the optimal or minimum amount of time a patient with newly diagnosed OSA should be on CPAP therapy prior to surgery to decrease the risk of perioperative complications. Therefore, while no specific recommendations can be made regarding the optimal duration of CPAP therapy prior to surgery for a patient with newly diagnosed OSA, it is reasonable to incorporate some time for adaptation to the device into the preoperative period. The risk of anastomotic complications is not increased by CPAP use in the immediate postoperative period following Roux-en-Y gastric bypass based on the existing literature. 39 It has also been suggested that postoperative CPAP and Bi-level PAP can be safely omitted following gastric bypass if they are observed in a monitored setting and their pulmonary status is optimized by aggressive incentive spirometry and early ambulation. 31  Postoperative use of CPAP should not be viewed as potentially adverse to outcomes following bariatric surgery due to any such concerns, and its use should be employed by bariatric surgeons based on the patient’s pulmonary status postoperatively.

Surgical Treatment

Although various surgical procedures are available to increase the posterior airspace to treat OSA, no surgical treatment is 100% effective. 40  A variety of extirpative and reconstructive surgical procedures can be performed to address upper-airway soft tissue obstruction or abnormalities that contribute to OSA.  Preoperative pharyngeal anatomy, severity of OSA and patient preference (recovery time, risk of prolonged facial paresthesias and malocclusion) all are factors determining surgical choice.   Tracheostomy may be used as a temporizing bypass approach.  Soft tissue removal procedures include tonsillectomy, adenoidectomy, uvulopalatoplasty, and even partial glossectomy.  Septoplasty has been employed, as have other skeletal and soft tissue modifications.  Although maxillomandibular advancement is the most effective craniofacial surgery for the treatment of OSA in adults (86% effective, 43% cure), uvulopalatopharyngoplasty (UPPP) is the most widely performed OSA pharyngeal surgical technique (50% effective, 16% cure rate). 40,41  However, UPPP has not been shown to be effective in patients with clinically severe obesity with a BMI > 35 kg/m2.

Treatment of Obstructive Sleep Apnea with Bariatric Surgery

OSA is associated with obesity and a positive correlation between increasing BMI and sleep apnea severity has been supported. 1,23,42,43  A ten percent increase in weight predicted a 6-fold increase in the odds of developing moderate-to-severe OSA.44  Weight loss by any method, including that following bariatric surgery, is a well-documented treatment for OSA.  In general, many patients after bariatric surgery will develop clinical improvement or resolution of symptoms of OSA, regardless of whether a normal BMI is ever achieved, as even a modest weight loss of 10-20% has been associated with improvement of symptoms and greater than 26% reduction in AHI. 44  It is apparent that not all causes of OSA are related to obesity, however, and it is likely that not all patients with OSA will resolve despite bariatric surgery.  Bariatric surgery has been shown to reduce truncal obesity; whether or not there are comparable changes in the upper airway has not been well established. 45  In a recently published meta-analysis evaluating the effects of surgical weight loss on the apnea-hypopnea index, the reduction in AHI was found to be 71%. 46

Data in the literature demonstrates subjective improvement in symptoms of OSA after bariatric surgery.  Such benefits include improvement in self-reported postoperative sleep quality and the reduction in daytime sleepiness after Roux-en-Y gastric bypass (RYGB) and vertical banded gastroplasty (VBG) 47 , and laparoscopic adjustable gastric banding (LAGB). 48,49  Improvement in validated quality of life scores was shown with both LAGB and RYGB. 50-52  Improvement in Epworth Sleepiness Scores have been demonstrated after LAGB 48-50 , and RYGB. 5,30,49,52  Other still somewhat subjective parameters of decreased use of CPAP and decreased CPAP pressure requirements have been shown to occur in bariatric patients after LAGB 48,50 and after RYGB. 30,51,52

Objective parameters regarding severity of OSA have been shown to improve after bariatric procedures and associated weight loss.  These include RDI or AHI score improvement for LAGB 48,50 ,VBG 47,53 and RYGB. 5,30,47,51-54  Patients who have significant weight loss after RYGB5, 30,51 and LAGB48 have been shown to demonstrate improvements in postoperative versus preoperative oxygen saturation.  Patients undergoing bariatric surgery with postoperative polysomnography testing have shown improved sleep efficiency and increased amounts of REM sleep after VBG 47,53 , LAGB 48,50 ,  and RYGB. 5,30,47,53  Severity of OSA is often also documented as being improved after these operations, although when strictly measured many patients do have mild OSA for which they take no treatment.  In one meta-analysis, more than 62% of patients were found to have significant residual disease after bariatric surgery, with an AHI of more than 15. 46  The severity of preoperative OSA often influences the degree to which OSA improves or resolves after bariatric surgery. 30,48

A more controversial aspect of the effect of bariatric surgery on postoperative OSA and sleep quality is that most of the evidence fails to show a significant correlation between the BMI and percentage of excess weight loss after surgery to the change in the RDI or AHI.  This has been reported for VBG 53 , LAGB 48 , and RYGB. 5,52,53  Only one study showed a correlation between self-reported symptoms of the patient’s sleepiness and weight change49, while one study showed a correlation between BMI and RDI score. 5  Weight regain after both VBG and RYGB has been shown to be associated with a recurrence of OSA symptoms. 47,53

These data suggest that although there is significant improvement of OSA after bariatric surgery, many patients may still need treatment of OSA based on their AHI.  Since the absence of clinical symptoms does not necessarily correlate with normalization of AHI and/or severity of sleep apnea, surgeons should consider repeat PSG testing or a CPAP titration study after significant weight loss has occurred. There is currently no consensus regarding indications or timing for repeat PSG either in the general population or for those individuals that have undergone bariatric surgery. Consideration should be given to performing repeat PSG when evaluating patients who present after significant weight regain or reemergence of prior resolved conditions such as diabetes or hypertension, especially if reoperative surgery is being considered.

Postoperative Monitoring and Care of Patients with OSA Undergoing Bariatric Surgery

Data regarding the appropriate postoperative monitoring and care of patients with OSA undergoing bariatric surgery has increased greatly in the past decade, and is an evolving body of published experience.  More recent reports contradict some older more stringent recommendations.

Published guidelines with more conservative and strict standards for postoperative monitoring include the American Society of Anesthesiology guidelines, which state bariatric patients should have continuous monitoring during and after surgical intervention, including continuous pulse oximetry and emergency airway equipment nearby.

Continuous pulse oximetry (in a critical care or step-down unit or by a dedicated, appropriately trained professional observer in the patient’s room) is felt to reduce the likelihood of complications among patients with OSA. 55  Intermittent pulse oximetry or continuous bedside oximetry without continuous observation is alleged, by these guidelines, to not provide the same level of patient safety. 55  Another report recommends continuous monitoring should be maintained for as long as patients remain at increased risk and for at least 3 hours beyond the standard observation time of their non-OSA counterparts. 56  That group also recommends that patients can be safely discharged from the monitored setting once oxygen saturation above 90% can be maintained on room air including during sleep, there is no hypoxemia/airway obstruction when the patient is left undisturbed, and patients no longer require parenteral narcotics.  Such guidelines are clearly relevant for inpatient postoperative hospitalizations, but are not readily applicable to outpatient procedures such as LAGB, and they do not account for patients with undiagnosed sleep apnea.

In contrast to these published recommendations, other reports in the literature have recently reviewed experiences where ICU type monitoring was not routinely used for patients with OSA.  Jensen et al 31 reported an experience of over 1000 laparoscopic RYGB patients in which over 800 did not have clinically-proven OSA.  A postoperative program of no routine use of CPAP, spirometry, and early ambulation, was associated with a very low incidence of pulmonary complications.  Grover et al 57 reported that ICU monitoring was not used for their bariatric patients undergoing laparoscopic RYGB.  Over 200 of 650 patients undergoing surgery had OSA, and that group had no increase in overall or pulmonary complications despite non-routine use of ICU in their postoperative care.

Postoperative monitoring of the bariatric surgical patient with OSA depends on a variety of factors including type of procedure, approach (laparoscopic vs. open), severity of sleep apnea, other patient comorbidities and individual facility capabilities. Minimum requirements include pulse oximetry or capnography in the post-anesthesia care unit and in the surgical ward.  The majority of patients with OSA can be safely monitored in this fashion. 57  Select higher risk patients, including males, BMI >6 0 , severe OSA, and age > 50 may be monitored in an ICU setting at the discretion of the surgeon. 58,59

Patients with diagnosed OSA who undergo bariatric surgery, and who routinely use CPAP or are prescribed to use it, should be prepared to use CPAP in the postoperative setting if ordered by the surgeon.  It is often best if the patient brings their own CPAP mask, with or without their machine, with them to the hospital.  This ensures the equipment fits the patient and is readily available for use in the postoperative period.

Summary Recommendations

Based on the evidence in the literature to date, the following guidelines regarding OSA in the bariatric surgery patient and its perioperative management are recommended:

  1. OSA is highly prevalent in the bariatric patient population.  The high prevalence demonstrated in some studies suggests that consideration be given to testing all patients, and especially those with any preoperative symptoms suggesting obstructive sleep apnea.
  2. Untreated OSA is yet another comorbidity observed with high prevalence in the bariatric patient population that leads to increased mortality and increased medical disability from several cardiovascular diseases.  These observations further emphasize the value of bariatric surgery as a potentially definitive treatment for OSA in severely obese patients.
  3. Patients who have documented moderate to severe OSA should be strongly encouraged to accept treatment preoperatively with CPAP and to use it postoperatively until clinical evaluation demonstrates resolution of OSA.
  4. These patients should also bring their CPAP machines, or at least their masks, with them at the time of surgery and use them following bariatric surgery at the discretion of the surgeon.
  5. All commonly performed bariatric operations that have been assessed for impact on OSA have shown evidence for significant relief of subjective symptoms of OSA and improvement of objective parameters of OSA that may not always correlate with amount of weight lost.
  6. Since bariatric surgery produces many improvements in the quality of life and other co-existing medical conditions for severely obese patients with OSA, it should be considered as the initial treatment of choice for OSA in this patient population as opposed to surgical procedures directed at the mandible or tissues of the palate.
  7. Routine pulse oximetry or capnography for postoperative monitoring of patients with OSA after bariatric surgery should be utilized, but the majority of these patients do not routinely require an ICU setting.
  8. No clear guidelines exist upon which to base recommendations for retesting for OSA following bariatric surgery.  However, strong consideration should be given to retesting patients who present years after bariatric surgery with regain of weight, a history of previous OSA, and who are being reevaluated for appropriate medical and potential reoperative surgical therapy.

Peri-operative Management of Obstructive Sleep Apnea Position Statement and Standard of Care

These guidelines and recommendations are not intended to provide inflexible rules or requirements of practice and are not intended, nor should they be used, to state or establish a local, regional, or national legal standard of care.  Ultimately, there are various appropriate treatment modalities for each patient, and surgeons must use their judgment in selecting from among the different feasible treatment options.

The ASMBS cautions against the use of these guidelines and recommendations in litigation in which the clinical decisions of a physician are called into question.  The ultimate judgment regarding appropriateness of any specific procedure or course of action must be made by the physician in light of all the circumstances presented.  Thus, an approach that differs from these guidelines or recommendations, standing alone, does not necessarily imply that the approach was below the standard of care.  To the contrary, a conscientious physician may responsibly adopt a course of action different from that set forth in the guidelines when, in the reasonable judgment of the physician, such course of action is indicated by the condition of the patient, limitations on available resources, or advances in knowledge or technology.  All that should be expected is that the physician will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient in order to deliver effective and safe medical care.  The sole purpose of these guidelines is to assist practitioners in achieving this objective.


  1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-39.
  2. Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994;18(3):173-7.
  3. O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg. 2004;14(1):23-6.
  4. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg. 2003;13(5):676-83.
  5. Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg. 2003;13(1):58-61.
  6. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: The busselton health study. Sleep. 2008;31(8):1079-85.
  7. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. cooperative group burgos-santander. N Engl J Med. 1999;340(11):847-51.
  8. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897-904.
  1. Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, Lopez JA, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000;161(2 Pt 1):375-80.
  2. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496-506.
  3. Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134-41.
  4. Sharma S, Malur A, Marshall I, Huizar I, Barna BP, Pories W, Dohm L, Kavuru MS, Thomassen MJ. Alveolar macrophage activation in obese patients with obstructive sleep apnea. Surgery. 2012 Jan;151(1):107-12.
  5. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151-8.
  6. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352(12):1206-14.
  7. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The sleep heart health study. Am J Respir Crit Care Med. 2006;173(8):910-6.
  8. Duran-Cantolla J, Aizpuru F, Martinez-Null C, Barbe-Illa F. Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Med Rev. 2009;13(5):323-31.
  9. Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168(5):522-30.
  10. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anaesth. 2010;57(5):423-38.
  11. Norman D, Loredo JS. Obstructive sleep apnea in older adults. Clin Geriatr Med. 2008;24(1):151-65.
  12. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med. 2005;118(9):948-56.
  13. Mokhlesi B. Positive airway pressure titration in obesity hypoventilation syndrome: Continuous positive airway pressure or bilevel positive airway pressure. Chest. 2007;131(6):1624-6.
  14. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, Wahed AS, Berk P, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445-54.
  15. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-5.
  16. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144–148.
  17. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163:608–613.
  18. Summers CL, Stradling JR, Baddeley RM. Treatment of sleep apnoea by vertical gastroplasty. Br J Surg. 1990;77(11):1271-2.
  19. Kyzer S, Charuzi I. Obstructive sleep apnea in the obese. World J Surg. 1998;22(9):998-1001.
  20. Hallowell PT, Stellato TA, Schuster M, Graf K, Robinson A, Crouse C, et al. Potentially life-threatening sleep apnea is unrecognized without aggressive evaluation. Am J Surg. 2007;193(3):364-67.
  21. Palla A, Digiorgio M, Carpene N, Rossi G, D’Amico I, Santini F, et al. Sleep apnea in morbidly obese patients: Prevalence and clinical predictivity. Respiration. 2009;78(2):134-40.
  22. Haines KL, Nelson LG, Gonzalez R, Torrella T, Martin T, Kandil A, et al. Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery. 2007;141(3):354-8.
  23. Jensen C, Tejirian T, Lewis C, Yadegar J, Dutson E, Mehran A. Postoperative CPAP and BiPAP use can be safely omitted after laparoscopic roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(4):512-4.
  24. Chai CL, Pathinathan A, Smith B. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006;18(4):CD005308.
  25. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;19(3):CD001106.
  26. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J. 2008;15(7):365-9.
  27. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest. 1993;103(6):1675-80.
  28. O’Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: The sleep heart health study. Am J Respir Crit Care Med. 2009;179(12):1159-64.
  29. Tomfohr LM, Ancoli-Israel S, Loredo JS, Dimsdale JE. Effects of continuous positive airway pressure on fatigue and sleepiness in patients with obstructive sleep apnea: Data from a randomized controlled trial. Sleep. 2011;34(1):121-6.
  30. Haensel A, Norman D, Natarajan L, Bardwell WA, Ancoli-Israel S, Dimsdale JE. Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: A double-blind trial. Sleep Breath. 2007;11(4):239-44.
  31. Ramirez A, Lalor PF, Szomstein S, Rosenthal RJ. Continuous positive airway pressure in immediate postoperative period after laparoscopic roux-en-Y gastric bypass: Is it safe? Surg Obes Relat Dis. 2009;5(5):544-6.
  32. Holty JE, Guilleminault C. Surgical options for the treatment of obstructive sleep apnea. Med Clin North Am. 2010;94(3):479-515.
  33. Khan A, Ramar K, Maddirala S, Friedman O, Pallanch JF, Olson EJ. Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: The mayo clinic experience. Mayo Clin Proc. 2009;84(9):795-800.
  34. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of obstructive sleep apnea: A population-based perspective. Expert Rev Respir Med. 2008;2(3):349-64.
  35. Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med. 2005;165(20):2408-13.
  36. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015-21.
  37. Suratt PM, McTier RF, Findley LJ, Pohl SL, Wilhoit SC. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest. 1987;92(4):631-7.
  38. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: A meta-analysis. Am J Med. 2009;122(6):535-42.
  39. Charuzi I, Lavie P, Peiser J, Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: Short- and long-term follow-up. Am J Clin Nutr. 1992;55(2 Suppl):594S-6S.
  40. Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of obstructive sleep apnea after surgical weight loss. J Clin Sleep Med. 2008;4(4):333-8.
  41. Grunstein RR, Stenlof K, Hedner JA, Peltonen M, Karason K, Sjostrom L. Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep. 2007;30(6):703-10.
  42. Dixon JB, Schachter LM, O’Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes (Lond). 2005;29(9):1048-54.
  43. Guardiano SA, Scott JA, Ware JC, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest. 2003;124(4):1615-9.
  44. Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea-hypopnea syndrome: The impact of bariatric surgery. Obes Surg. 2007;17(1):95-9.
  45. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest. 1994;106(6):1702-4.
  46. Marti-Valeri C, Sabate A, Masdevall C, Dalmau A. Improvement of associated respiratory problems in morbidly obese patients after open roux-en-Y gastric bypass. Obes Surg. 2007;17(8):1102-10.
  47. Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Cote CJ, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: A report by the american society of anesthesiologists task force on perioperative management of patients with obstructive sleep apnea. Anesthesiology. 2006;104(5):1081-93.
  48. Schumann R, Jones SB, Cooper B, Kelley SD, Bosch MV, Ortiz VE, et al. Update on best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery, 2004-2007. Obesity (Silver Spring). 2009;17(5):889-94.
  49. Grover BT, Priem DM, Mathiason MA, Kallies KJ, Thompson GP, Kothari SN. Intensive care unit stay not required for patients with obstructive sleep apnea after laparoscopic roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(2):165-70.
  50. DeMaria EJ, Carmody BJ. Perioperative management of special populations: Obesity. Surg Clin North Am. 2005;85(6):1283-89.
  51. Helling TS, Willoughby TL, Maxfield DM, Ryan P. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery. Obes Surg. 2004;14(8):1036-41.
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now